

Fundamental dimension Equity attribute | ABBVPeer $282.78▼-0.92% Cap $499.7BP/E 79.7x QuantScore55/100 | AMGNPeer $424.94▼-1.75% Cap $229.7BP/E 26.2x QuantScore58/100 | AZNLeader $170.90▼-0.97% Cap $265.0BP/E 25.6x QuantScore59/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
86/100 |
96/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 39/100 | 85/100 | 80/100 |
Health Piotroski, Altman Z, leverage & liquidity | 49/100 | 32/100 | 50/100 |
Growth Revenue / earnings growth & margins | 37/100 | 59/100 | 56/100 |
Sentiment Analyst ratings, targets & revisions | 66/100 | 16/100 | 35/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 79.7x | 26.2x | 25.6x |
Forward P/E (next FY) | 20.3x | 18.4x | 16.7x |
EV / EBITDA (TTM) | 26.6x | 15.5x | 14.3x |
Price / Sales | 7.8x | 6.0x | 4.3x |
Price / Free Cash Flow | 27.4x | 22.6x | 31.5x |
PEG ratio | 1.17 | 0.83 | 1.09 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 9 / 9 | 8 / 9 | 8 / 9 |
Altman Z-Score | 2.70 (Grey) | 2.31 (Grey) | 3.45 (Safe) |
Total debt / equity | -11.93 | 4.90 | 0.64 |
Quick ratio | 0.7x | 1.1x | 0.7x |
Interest coverage | 6.5x | 4.7x | 8.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +8.6% | +9.9% | +8.6% |
Net income growth YoY | -1.2% | +88.5% | +45.8% |
Gross margin (TTM) | 71.5% | 72.7% | 79.3% |
Operating margin (FY) | 32.8% | 29.1% | 23.4% |
FCF margin (FY) | 29.1% | 22.0% | 14.8% |
5. Trailing price performancePrice change over period |
1M return | +7.8% | +10.2% | +5.0% |
3M return | +11.2% | +16.0% | +1.9% |
6M return | +42.1% | +19.6% | -10.8% |
Year to date | +25.0% | +29.8% | -2.3% |
1Y return | +25.1% | +40.1% | +1.9% |
3Y return | +97.4% | +51.4% | +38.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $123.86 -56.2% premium | $860.35 +102.5% upside | $483.37 +182.8% upside |
Wall Street consensus target | $292.21 +3.3% · range $235.00–$320.00 | $401.16 -5.6% · range $230.00–$500.00 | $186.67 +9.2% · range $158.00–$216.00 |
Consensus stance | 73% Buy25% Hold2% Sell | 54% Buy39% Hold7% Sell | 49% Buy37% Hold15% Sell |